View in EDS

FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.

Saved in:
Bibliographic Details
Title: FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
Authors: Sullivan PM; Seattle Children's Research Institute, Seattle, Washington., Kumar R; Seattle Children's Research Institute, Seattle, Washington., Li W; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Hoglund V; Seattle Children's Research Institute, Seattle, Washington., Wang L; Seattle Children's Research Institute, Seattle, Washington., Zhang Y; Seattle Children's Research Institute, Seattle, Washington., Shi M; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Beak D; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Cheuk A; NCI, CCR, National Institutes of Health, Bethesda, Maryland., Jensen MC; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Seattle Children's Therapeutics, Seattle, Washington., Khan J; NCI, CCR, National Institutes of Health, Bethesda, Maryland., Dimitrov DS; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Orentas RJ; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Oct 07; Vol. 21 (10), pp. 1608-1621.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35877472
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sullivan+PM%22">Sullivan PM</searchLink>; Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kumar+R%22">Kumar R</searchLink>; Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Hoglund+V%22">Hoglund V</searchLink>; Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Wang+L%22">Wang L</searchLink>; Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; Seattle Children's Research Institute, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Shi+M%22">Shi M</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Beak+D%22">Beak D</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Cheuk+A%22">Cheuk A</searchLink>; NCI, CCR, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Jensen+MC%22">Jensen MC</searchLink>; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.; Seattle Children's Therapeutics, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Khan+J%22">Khan J</searchLink>; NCI, CCR, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Dimitrov+DS%22">Dimitrov DS</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Orentas+RJ%22">Orentas RJ</searchLink>; Seattle Children's Research Institute, Seattle, Washington.; Department of Pediatrics, University of Washington, Seattle, Washington.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2022 Oct 07; Vol. 21 (10), pp. 1608-1621.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35877472
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-22-0059
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1608
    Titles:
      – TitleFull: FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sullivan PM
      – PersonEntity:
          Name:
            NameFull: Kumar R
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Hoglund V
      – PersonEntity:
          Name:
            NameFull: Wang L
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Shi M
      – PersonEntity:
          Name:
            NameFull: Beak D
      – PersonEntity:
          Name:
            NameFull: Cheuk A
      – PersonEntity:
          Name:
            NameFull: Jensen MC
      – PersonEntity:
          Name:
            NameFull: Khan J
      – PersonEntity:
          Name:
            NameFull: Dimitrov DS
      – PersonEntity:
          Name:
            NameFull: Orentas RJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 10
              Text: 2022 Oct 07
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1